Biancosino Christian, Krüger Marcus, Vollmer Ekkehard, Welker Lutz
Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Medical School Hannover, Hannover, Germany.
Department of Thoracic Surgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Heusnerstraße 40, 42115, Wuppertal, Germany.
Diagn Pathol. 2016 Jul 7;11(1):59. doi: 10.1186/s13000-016-0510-6.
Due to therapeutic implications with regard to both efficiency and safety of chemotherapy agents it is important to differentiate between subtypes of NSCLC. Up to today we experience a continuous reservation regarding the use of fine needle aspiration cytology. The aim of the present study is to estimate the value of cytologic criteria for lung cancer typing on small biopsies independent from all possible technique failures.
Between January 1997 and December 2008 760 intraoperative FNAC- (fine needle aspiration cytology) specimens from 702 patients have been examined. Cytologic evaluation and immediate communication of results to the surgeons followed. Afterwards, intraoperative cytologic findings were compared with final histologic diagnoses of the resected specimens.
Intraoperative cytologic analysis yielded a sensitivity of 94.8 %, a specificity of 98.8 %. An overall positive predictive value of 99.8 % with respect to final histologic analysis of primary lung cancer was achieved. The highest value could be reached for adenocarcinomas, followed by carcinoids and squamous cell carcinomas.
Lung cancer typing according to cytologic criteria is feasible and accurate as well as comparable with results of histologic analysis on small specimens. Herewith, clinicians can come up to the increasing demands on minimally invasive harvested specimens with regard to therapeutic implications.
由于化疗药物在有效性和安全性方面的治疗意义,区分非小细胞肺癌的亚型很重要。直到如今,我们在细针穿刺细胞学检查的使用上仍存在持续的保留态度。本研究的目的是评估在排除所有可能的技术失败因素后,小活检标本上肺癌分型的细胞学标准的价值。
在1997年1月至2008年12月期间,对702例患者的760份术中细针穿刺细胞学(FNAC)标本进行了检查。随后进行了细胞学评估并将结果立即告知外科医生。之后,将术中细胞学检查结果与切除标本的最终组织学诊断结果进行比较。
术中细胞学分析的敏感性为94.8%,特异性为98.8%。对原发性肺癌最终组织学分析的总体阳性预测值达到99.8%。腺癌的阳性预测值最高,其次是类癌和鳞状细胞癌。
根据细胞学标准进行肺癌分型是可行且准确的,并且与小标本的组织学分析结果相当。据此,临床医生能够满足对微创获取标本在治疗意义方面日益增长的需求。